BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 26969087)

  • 1. Computational studies of plasma lipoprotein lipids.
    Pan L; Segrest JP
    Biochim Biophys Acta; 2016 Oct; 1858(10):2401-2420. PubMed ID: 26969087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of discoidal high density lipoproteins: a combined computational-experimental approach.
    Gu F; Jones MK; Chen J; Patterson JC; Catte A; Jerome WG; Li L; Segrest JP
    J Biol Chem; 2010 Feb; 285(7):4652-65. PubMed ID: 19948731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of activation of lecithin:cholesterol acyltransferase by apolipoprotein A-I.
    Jones MK; Catte A; Li L; Segrest JP
    Biochemistry; 2009 Dec; 48(47):11196-210. PubMed ID: 19860440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MD simulations suggest important surface differences between reconstituted and circulating spherical HDL.
    Segrest JP; Jones MK; Catte A
    J Lipid Res; 2013 Oct; 54(10):2718-32. PubMed ID: 23856070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Sticky" and "promiscuous", the yin and yang of apolipoprotein A-I termini in discoidal high-density lipoproteins: a combined computational-experimental approach.
    Jones MK; Gu F; Catte A; Li L; Segrest JP
    Biochemistry; 2011 Mar; 50(12):2249-63. PubMed ID: 21329368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of lipids in spheroidal high density lipoproteins.
    Vuorela T; Catte A; Niemelä PS; Hall A; Hyvönen MT; Marrink SJ; Karttunen M; Vattulainen I
    PLoS Comput Biol; 2010 Oct; 6(10):e1000964. PubMed ID: 21060857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconsideration of hydrophobic lipid distributions in lipoprotein particles.
    Kumpula LS; Kumpula JM; Taskinen MR; Jauhiainen M; Kaski K; Ala-Korpela M
    Chem Phys Lipids; 2008 Sep; 155(1):57-62. PubMed ID: 18611396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia.
    Martinez LR; Santos RD; Miname MH; Deus DF; Lima ES; Maranhão RC
    Metabolism; 2013 Aug; 62(8):1061-4. PubMed ID: 23540443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I.
    Rye KA; Barter PJ
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):421-8. PubMed ID: 14592845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms responsible for the compositional heterogeneity of nascent high density lipoprotein.
    Lund-Katz S; Lyssenko NN; Nickel M; Nguyen D; Chetty PS; Weibel G; Phillips MC
    J Biol Chem; 2013 Aug; 288(32):23150-60. PubMed ID: 23836906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interfacial properties of high-density lipoprotein-like lipid droplets with different lipid and apolipoprotein A-I compositions.
    Koivuniemi A; Sysi-Aho M; Orešič M; Ollila S
    Biophys J; 2013 May; 104(10):2193-201. PubMed ID: 23708359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
    Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
    J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesteryl ester diffusion, location and self-association constraints determine CETP activity with discoidal HDL: excimer probe study.
    Dergunov AD; Shabrova EV; Dobretsov GE
    Arch Biochem Biophys; 2014 Dec; 564():211-8. PubMed ID: 25449063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein AI tertiary structures determine stability and phospholipid-binding activity of discoidal high-density lipoprotein particles of different sizes.
    Chen B; Ren X; Neville T; Jerome WG; Hoyt DW; Sparks D; Ren G; Wang J
    Protein Sci; 2009 May; 18(5):921-35. PubMed ID: 19384992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes.
    Maïga SF; Kalopissis AD; Chabert M
    Biochimie; 2014 Jan; 96():56-66. PubMed ID: 24012775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma kinetics of an LDL-like non-protein nanoemulsion and transfer of lipids to high-density lipoprotein (HDL) in patients with rheumatoid arthritis.
    Pozzi FS; Maranhão RC; Guedes LK; Borba EF; Laurindo IM; Bonfa E; Vinagre CG
    J Clin Lipidol; 2015; 9(1):72-80. PubMed ID: 25670363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of apolipoproteins on the structure and function of spheroidal, reconstituted high density lipoproteins.
    Rye KA; Barter PJ
    J Biol Chem; 1994 Apr; 269(14):10298-303. PubMed ID: 8144610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural studies of discoidal lipoprotein A-I.
    Koppaka V
    Cell Mol Life Sci; 2001 Jun; 58(7):885-93. PubMed ID: 11497237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.
    Chroni A; Kan HY; Shkodrani A; Liu T; Zannis VI
    Biochemistry; 2005 Mar; 44(10):4108-17. PubMed ID: 15751988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of human plasma phospholipid transfer protein mass and activity.
    Jauhiainen M; Ehnholm C
    Methods; 2005 Jun; 36(2):97-101. PubMed ID: 15893933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.